AVD AMERICAN VANGUARD CORP
Agricultural Chemicals · NYSE · SEC CIK 5981 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY-5.8%
TTM net income YoY46.6%
TTM EPS YoY47.5%
Revenue 3-yr CAGR-4.2%
Net income 3-yr CAGR—
Margins
Gross margin28.4%
Operating margin-5.7%
Net margin-12.0%
FCF margin-2.5%
EBITDA margin-5.8%
Returns
ROE-31.2%
ROA-9.1%
ROIC (approx.)-6.1%
Asset turnover0.76x
Leverage & solvency
Liabilities / assets75.4%
Debt / equity1.64x
Current ratio2.02x
Interest coverage-0.96x
Cash quality & payout
Operating cash flow / net income0.11x
Accruals ratio-8.1%
Payout ratio—
Capex / revenue1.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $108.38M | $116.75M | $123.57M | $150.69M | $119.31M | $129.31M | $115.80M | $165.65M |
| Cost of revenue | $82.12M | $82.04M | $85.15M | $108.08M | $85.10M | $88.77M | $85.61M | $142.80M |
| Gross profit | $26.25M | $34.71M | $38.42M | $42.61M | $34.21M | $40.55M | $30.19M | $22.84M |
| R&D expense | $5.34M | $6.48M | $5.27M | $6.02M | $5.65M | $5.80M | $5.68M | $7.18M |
| SG&A expense | $25.80M | $26.62M | $27.71M | $28.64M | $26.75M | $28.62M | $26.63M | $32.75M |
| Operating income | -$7.96M | -$303,000 | $1.89M | -$21.85M | -$6.50M | $4.37M | -$4.31M | -$70.03M |
| Interest expense | $9.15M | $9.13M | $5.79M | $5.33M | $4.92M | $4.45M | $3.77M | $4.56M |
| Pretax income | -$17.13M | -$9.48M | -$4.02M | -$27.11M | -$11.94M | -$84,000 | -$8.07M | -$77.45M |
| Income tax | $536,000 | $383,000 | $124,000 | $1.10M | $422,000 | $765,000 | $387,000 | $12.97M |
| Net income | -$17.67M | -$9.87M | -$4.14M | -$28.21M | -$12.36M | -$849,000 | -$8.46M | -$90.43M |
| EBITDA | -$6.38M | $1.28M | $6.57M | -$30.60M | -$4.88M | $6.03M | $434,000 | -$81.47M |
| EPS (basic) | -0.61 | -0.34 | -0.14 | — | -0.43 | -0.03 | -0.30 | — |
| EPS (diluted) | -0.61 | -0.34 | -0.14 | — | -0.43 | -0.03 | -0.30 | — |
| Weighted avg. shares (diluted) | 28.77M | 28.65M | 28.65M | — | 28.51M | 28.34M | 28.27M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $83.91M | $43.90M | $70.91M | $12.43M | $16.80M | $14.48M | $11.80M | $12.51M |
| Receivables | $142.68M | $174.61M | $179.34M | $160.51M | $167.14M | $169.48M | $159.56M | $169.74M |
| Inventory | $194.08M | $181.38M | $175.04M | $176.03M | $199.00M | $191.50M | $184.60M | $179.29M |
| Current assets | $438.40M | $417.75M | $443.55M | $370.52M | $406.47M | $399.33M | $377.85M | $378.89M |
| PP&E, net | $51.96M | $51.18M | $51.72M | $53.04M | $55.80M | $56.10M | $57.02M | $58.17M |
| Goodwill | — | — | — | $0 | $21.04M | $20.80M | $20.29M | $19.70M |
| Intangibles | $139.81M | $133.19M | $136.07M | $138.75M | $143.41M | $146.17M | $147.67M | $150.50M |
| Total assets | $663.41M | $635.34M | $665.24M | $596.54M | $655.01M | $651.98M | $631.59M | $636.72M |
| Current liabilities | $217.23M | $168.80M | $190.92M | $209.45M | $230.17M | $208.74M | $213.06M | $232.35M |
| Short-term debt | $3.75M | $2.25M | $2.25M | $0 | $0 | $0 | $0 | $0 |
| Long-term debt | $263.94M | $265.37M | $264.38M | $174.00M | $182.25M | $189.50M | $167.50M | $147.33M |
| Total debt | $267.69M | $267.62M | $266.63M | $174.00M | $182.25M | $189.50M | $167.50M | $147.33M |
| Total liabilities | $500.29M | $453.96M | $475.62M | $404.14M | $434.02M | $421.16M | $404.23M | $403.61M |
| Shareholders' equity | $163.12M | $181.39M | $189.62M | $192.40M | $220.99M | $230.82M | $227.35M | $233.11M |
| Net debt | $183.78M | $223.72M | $195.72M | $161.57M | $165.46M | $175.02M | $155.69M | $134.82M |
| Cash flow statement | ||||||||
| Operating cash flow | $48.11M | -$25.02M | -$35.44M | $5.95M | $12.69M | -$19.26M | -$20.58M | $33.77M |
| Capital expenditure | $2.35M | $1.35M | $971,000 | $1.52M | $1.38M | $589,000 | $431,000 | $1.17M |
| Free cash flow | $45.76M | -$26.37M | -$36.41M | $4.43M | $11.31M | -$19.85M | -$21.01M | $32.60M |
| Investing cash flow | -$7.40M | -$1.45M | -$973,000 | -$1.56M | -$985,000 | -$611,000 | -$446,000 | -$242,000 |
| Financing cash flow | -$702,000 | -$639,000 | $95.01M | -$8.36M | -$9.42M | $21.68M | $19.80M | -$32.28M |
| Depreciation & amortization | $1.59M | $1.58M | $4.68M | -$8.75M | $1.62M | $1.66M | $4.74M | -$11.45M |
| Stock-based compensation | $327,000 | $388,000 | $186,000 | $275,000 | $760,000 | $422,000 | $559,000 | $525,000 |
| Dividends paid | — | — | — | $0 | $0 | $0 | $0 | $0 |
| Share buybacks | — | — | — | — | — | — | — | $0 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.